William E. Carson

机构：The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University Wexner Medical Center, Ohio State University Hospital, The Ohio State University · ORCID：0000-0001-7024-7533

发表论文 687 篇 · 总被引 21098 次 · h-index 76

代表论文

• Neoadjuvant PD-1 blockade in surgically resectable desmoplastic melanoma: cohort A of the phase 2 SWOG S1512 trial (2026 · Nature Cancer · 被引 4)
• Early life abuse and neglect in breast cancer survivors: Associations with physical and psychological health throughout diagnosis and survivorship (2026 · Journal of Traumatic Stress · 被引 1)
• Phase II Trial of Interleukin-12 Followed by Interferon Alfa-2b in Patients with Metastatic Malignant Melanoma: Results from CALGB 500001 (Alliance) (2026 · Cancer Immunology Research · 被引 1)
• Pre-treatment T-cell Transcriptional Signatures Predict Immunotherapy Outcomes in Melanoma (2026 · Research Square)
• Multicenter Phase I Study of Triapine in Combination with [177Lu]Lutetium-Dotatate in Patients with Well-Differentiated Neuroendocrine Tumors (ETCTN 10388) (2026 · Clinical Cancer Research)
• Data from Phase II Trial of Interleukin-12 Followed by Interferon Alfa-2b in Patients with Metastatic Malignant Melanoma: Results from CALGB 500001 (Alliance) (2026)